Paysign has achieved strong double-digit revenue growth year-over-year and expanded its market share significantly. The company now controls about 50% of the plasma donation center market after adding 132 new centers. Paysign maintains a healthy balance sheet and expects to improve its bottom-line financials.
Paysign, Inc. (NASDAQ:PAYS ) Q1 2025 Earnings Conference Call May 6, 2025 5:00 PM ET Company Participants Mark Newcomer - President & Chief Executive Officer Jeff Baker - Chief Financial Officer Conference Call Participants Operator Good afternoon. My name is Chelsea, and I will be your conference operator today.
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host First Quarter 2025 Earnings Call.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.